Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty

Anesthesiology

Volumn 99, Issue 3, 2003, Pages 552-560

  Mantilla, Carlos B ^a   Horlocker, Terese T ^a   Schroeder, Darrell R ^a   Berry, Daniel J ^a   Brown, David L ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ELECTIVE SURGERY; FEMALE; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL RISK;

AGED; ANESTHESIA; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0041825176     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200309000-00009     Document Type: Article

References (45)

1. Warwick D, Williams MH, Bannister GC: Death and thromboembolic disease after total hip replacement: A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg (Br) 1995; 77:6-10
2. Fender D, Harper WM, Thompson JR, Gregg PJ: Mortality and fatal pulmonary embolism after primary total hip replacement: Results from a regional hip register. J Bone Joint Surg (Br) 1997; 79:896-9
3. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W: Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158:1525-31
4. Wroblewski BM, Siney PD, Fleming PA: Fatal pulmonary embolism after total hip arthroplasty: Diurnal variations. Orthopedics 1998; 21:1269-71
5. Stulberg BN, Insall JN, Williams GW, Ghelman B: Deep-vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg (Am) 1984; 66:194-201
6. Planes A, Vochelle N, Fagola M: Total hip replacement and deep vein thrombosis: A venographic and necropsy study. J Bone Joint Surg (Br) 1990; 72:9-13
7. Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J: Prevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114:545-51
8. Francis CW, Pellegrini VD Jr, Marder VJ, Totterman S, Harris CM, Gabriel KR, Azodo MV, Leibert KM: Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992; 267:2911-5
9. Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D, Elliott CG, Panju A, Brant R: A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329:1370-6
10. Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 271:1780-5
11. Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge. J Bone Joint Surg (AM) 1999; 81:932-40
12. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL: Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip of knee arthroplasty. ANESTHESIOLOGY 2002; 96: 1140-6
13. Seligsohn U, Lubetsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-31
14. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277:642-5
15. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ: Cancer and venous thromboembolism. Am Heart J 1996; 132:850-5
16. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S: Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348:977-80
17. Kelsey JL, Wood PH, Charnley J: Prediction of thromboembolism following total hip replacement. Clin Orthop 1976; 247-58
18. Kim YH, Kim VE: Factors leading to low incidence of deep vein thrombosis after cementless and cemented total knee arthroplasty. Clin Orthop 1991; 119-24
19. Sharrock NE, Haas SB, Hargett MJ, Urquhart B, Insall JN, Scuderi G: Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg (Am) 1991; 73:502-6
20. Sharrock NE, Hargett MJ, Urquhart B, Peterson MG, Ranawat C, Insall J, Windsor R: Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty 1993; 8:133-9
21. Schlesselman JJ, Stolley PD: Research strategies, Case Control Studies Design, Conduct, Analysis. Edited by Schlesselman JJ. New York, Oxford University Press, 1982, pp 7-26
22. Berry DJ, Kessler M, Morrey BF: Maintaining a hip registry for 25 years: Mayo Clinic experience. Clin Orthop 1997; 344:61-8
23. Melton LJ III: History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71:266-74
24. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III: Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998; 158:585-93
25. American Society of Anesthesiologists: New classification of physical status. ANESTHESIOLOGY 1963; 24:111
26. Starsnic MA, Guarnieri DM, Norris MC: Efficacy and financial benefit of an anesthesiologist-directed university preadmission evaluation center. J Clin Anesth 1997; 9:299-305
27. Lemos MJ, Sutton D, Hozack WJ, Balderston RA, Booth RE Jr, Rothman RH: Pulmonary embolism in total hip and knee arthroplasty: Risk factors in patients on warfarin prophylaxis and analysis of the prothrombin time as an indicator of warfarin's prophylactic effect. Clin Orthop 1992; 282:158-63
28. Jiganti JJ, Goldstein WM, Williams CS: A comparison of the perioperative morbidity in total joint arthroplasty in the obese and nonobese patient. Clin Orthop 1993; 289:175-9
29. Benjamin J, Tucker T, Ballesteros P: Is obesity a contraindication to bilateral total knee arthroplasties under one anesthetic? Clin Orthop 2001; 392: 190-5
30. Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AG, Mannucci PM: Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost 1999; 81:879-86
31. White RH, Gettner S, Newman JM, Trauner KB, Romano PS: Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 2000; 343:1758-64
32. Rodgers A, Gray H, MacMahon S: Pharmacological thromboprophylaxis in hip and knee surgery: A survey of New Zealand orthopaedic surgeons. Aust NZ J Surg 1994; 64:167-72
33. Ansari S, Warwick D, Ackroyd CE, Newman JH: Incidence of fatal pulmonary embolism after 1,390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases. J Arthroplasty 1997; 12:599-602
34. Stern SH, Bowen MK, Insall JN, Scuderi GR: Cemented total knee arthroplasty for gonarthrosis in patients 55 years old or younger. Clin Orthop 1990; 260:124-9
35. Hyers TM, Hull RD, Weg JG: Antithrombotic therapy for venous thromboembolic disease. Chest 1986; 89(suppl):26-35
36. Hyers TM, Hull RD, Weg JG: Antithrombotic therapy for venous thromboembolic disease. Chest 1989; 95(suppl):37-51
37. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB: Prevention of venous thromboembolism. Chest 2001; 119(suppl): 132-75
38. Murray DW, Britton AR, Bulstrode CJ: Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg (Br) 1996; 78:863-70
39. Levine MN, Raskob G, Landefeld S, Kearon C: Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119(suppl):108-21
40. Klotz HP, Candinas D, Platz A, Horvath A, Dindo D, Schlumpf R, Largiader F: Preoperative risk assessment in elective general surgery. Br J Surg 1996; 83:1788-91
41. Wolters U, Wolf T, Stutzer H, Schroder T: ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77:217-22
42. Leung JM, Dzankic S: Relative importance of preoperative health status versus intraoperative factors in predicting postoperative adverse outcomes in geriatric surgical patients. J Am Geriatr Soc 2001; 49:1080-5
43. Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr: Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg 1995; 80:242-8
44. Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS: The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: A multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med 1998; 158: 873-8
45. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302